0001209191-20-038471.txt : 20200623
0001209191-20-038471.hdr.sgml : 20200623
20200623163011
ACCESSION NUMBER: 0001209191-20-038471
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200622
FILED AS OF DATE: 20200623
DATE AS OF CHANGE: 20200623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashton William
CENTRAL INDEX KEY: 0001474553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 20982523
MAIL ADDRESS:
STREET 1: C/O HARRISON CONSULTING GROUP
STREET 2: PO BOX 283
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-22
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001474553
Ashton William
11500 S. EASTERN AVE., SUITE 240
HENDERSON
NV
89052
1
0
0
0
Common Stock, $0.001 par value
2020-06-22
4
S
0
5000
3.25
D
41666
D
Stock Option (Right to Buy)
2.94
2020-06-18
4
A
0
60000
0.00
A
2030-06-18
Common Stock
60000
60000
D
All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
This stock option grant was previously reported on a Form 4 on June 19, 2020. This is an amendment to that Form 4 to reflect an inadvertent error in Column 7 under the "Amount or Number of Shares".
One third of the aggregate amount of option shares shall vest on each of June 18, 2021, 2022 and 2023, respectively.
/s/ Kurt A. Gustafson, attorney-in-fact for William L. Ashton
2020-06-23